Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: � Age 18 - 75 years � Female patients � Biopsy proven IDC (any grade) � Stage: T1-4b; N0-2; M0 � ER/PR/Her2neu-Any � ECOG PS 0-1 � 2DECHO-LVEF 50-60% � No history of prior anti-cancer treatment with radiotherapy, chemotherapy, or surgery � Patient must sign an informed consent before entry into the study
Exclusion criteria
Exclusion criteria: � Age >75 years and � Previous history of radiotherapy � Recurrent disease� Patients with significant co-morbid condition � History of previous malignancy � Not compliant for regular follow up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare Loco-regional recurrence free survival (LRRFS) at 5 yearsTimepoint: To compare Loco-regional recurrence free survival (LRRFS) at 5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Ipsilateral breast tumor recurrence (IBTR) at 5 years 2) To compare 5 year OS 3) To compare Distant metastasis free survival 4) Impact of annual PET CT scan for detection of early metastasisTimepoint: 5 years | — |
Countries
India
Contacts
National Cancer Institute, AIIMS, New Delhi